Fusion PharmaceuticalsI Stock Options
| FUSN Stock | USD 21.40 0.02 0.09% |
Fusion PharmaceuticalsI's option chain provides insight into all available option contracts written on Fusion PharmaceuticalsI's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Fusion PharmaceuticalsI's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Fusion option contract.
In The Money vs. Out of Money Option Contracts on Fusion PharmaceuticalsI
Analyzing Fusion PharmaceuticalsI's in-the-money options over time can help investors to take a profitable long position in Fusion PharmaceuticalsI regardless of its overall volatility. This is especially true when Fusion PharmaceuticalsI's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Fusion PharmaceuticalsI's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Fusion PharmaceuticalsI's stock while costing only a fraction of its price.
Fusion PharmaceuticalsI's latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 16.77 with a put-to-call open interest ratio of 0.86 over 22 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 41, with calls trading at the volume of 748. This yields a 0.05 put-to-call volume ratio. The Fusion PharmaceuticalsI option chain provides detailed quote and price information for the current Fusion PharmaceuticalsInc option contracts. It shows all of Fusion PharmaceuticalsI's listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
Fusion PharmaceuticalsI option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Fusion PharmaceuticalsI's lending market. For example, when Fusion PharmaceuticalsI's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Fusion PharmaceuticalsI, he or she must hedge the risk by shorting Fusion PharmaceuticalsI stock over its option's life.
2024-05-17
The chart above shows Fusion PharmaceuticalsI's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Fusion PharmaceuticalsI's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Fusion PharmaceuticalsI's option, there is no secondary market available for investors to trade.
Fusion PharmaceuticalsI's stock options are financial instruments that give investors the right to buy or sell shares of Fusion PharmaceuticalsInc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Fusion stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Fusion PharmaceuticalsI's stock price goes up or down, the stock options follow.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fusion PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. Please note that buying 'in-the-money' options on Fusion PharmaceuticalsI lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Fusion PharmaceuticalsI's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Fusion PharmaceuticalsI contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Fusion Stock moves the wrong way.
As of the 24th of April 2024, Stock Based Compensation is likely to grow to about 13.1 M, while Common Stock Shares Outstanding is likely to drop about 57.7 M. Fusion PharmaceuticalsInc In The Money Call Balance
When Fusion PharmaceuticalsI's strike price is surpassing the current stock price, the option contract against Fusion PharmaceuticalsInc stock is said to be in the money. When it comes to buying Fusion PharmaceuticalsI's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Fusion PharmaceuticalsInc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Fusion Current Options Market Mood
Fusion PharmaceuticalsI's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Fusion Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Fusion PharmaceuticalsI's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Fusion PharmaceuticalsI's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Fusion PharmaceuticalsI's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Fusion contract
Base on the Rule 16, the options market is currently suggesting that Fusion PharmaceuticalsInc will have an average daily up or down price movement of about 1.05% per day over the life of the 2024-05-17 option contract. With Fusion PharmaceuticalsI trading at USD 21.4, that is roughly USD 0.22. If you think that the market is fully incorporating Fusion PharmaceuticalsI's daily price movement you should consider buying Fusion PharmaceuticalsInc options at the current volatility level of 16.77%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Fusion |
Purchasing Fusion PharmaceuticalsI options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Fusion calls. Remember, the seller must deliver Fusion PharmaceuticalsInc stock to the call owner when a call is exercised.
Fusion PharmaceuticalsI Option Chain
When Fusion PharmaceuticalsI's strike price is surpassing the current stock price, the option contract against Fusion PharmaceuticalsInc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Fusion PharmaceuticalsI's option chain is a display of a range of information that helps investors for ways to trade options on Fusion. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Fusion. It also shows strike prices and maturity days for a Fusion PharmaceuticalsI against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $2.5 | 0.9937 | 7.0E-4 | 9 | 2024-05-17 | 18.7 - 19.3 | 18.6 | In |
Call | 2024-05-17 CALL at $5.0 | 0.9907 | 0.0016 | 63 | 2024-05-17 | 16.2 - 16.8 | 16.1 | In |
Call | 2024-05-17 CALL at $7.5 | 0.9675 | 0.0048 | 139 | 2024-05-17 | 13.6 - 14.2 | 13.8 | In |
Call | 2024-05-17 CALL at $10.0 | 0.9225 | 0.0094 | 514 | 2024-05-17 | 10.4 - 14.0 | 11.4 | In |
Call | 2024-05-17 CALL at $12.5 | 0.8862 | 0.0151 | 101 | 2024-05-17 | 8.3 - 11.5 | 8.8 | In |
Call | 2024-05-17 CALL at $15.0 | 0.9609 | 0.0181 | 418 | 2024-05-17 | 6.3 - 6.8 | 6.3 | In |
Call | 2024-05-17 CALL at $17.5 | 0.7762 | 0.0396 | 45 | 2024-05-17 | 3.8 - 6.5 | 3.8 | In |
Call | 2024-05-17 CALL at $20.0 | 0.8968 | 0.1438 | 189 | 2024-05-17 | 1.35 - 1.55 | 1.45 | In |
Call | 2024-05-17 CALL at $22.5 | 0.1232 | 0.2446 | 11593 | 2024-05-17 | 0.0 - 0.05 | 0.05 | Out |
Put | 2024-05-17 PUT at $20.0 | -0.0903 | 0.1395 | 10477 | 2024-05-17 | 0.0 - 0.05 | 0.05 | Out |
Put | 2024-05-17 PUT at $22.5 | -0.8209 | 0.241 | 83 | 2024-05-17 | 1.1 - 1.2 | 1.15 | In |
Put | 2024-05-17 PUT at $25.0 | -0.7501 | 0.0755 | 0 | 2024-05-17 | 3.2 - 5.0 | 3.8 | In |
Put | 2024-05-17 PUT at $30.0 | -0.8601 | 0.038 | 0 | 2024-05-17 | 7.9 - 9.9 | 0.0 | In |
Fusion PharmaceuticalsI Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Fusion PharmaceuticalsI Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Fusion Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fusion PharmaceuticalsI without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Fusion PharmaceuticalsI Corporate Management
Elected by the shareholders, the Fusion PharmaceuticalsI's board of directors comprises two types of representatives: Fusion PharmaceuticalsI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fusion. The board's role is to monitor Fusion PharmaceuticalsI's management team and ensure that shareholders' interests are well served. Fusion PharmaceuticalsI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fusion PharmaceuticalsI's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Leamon | Chief Officer | Profile | |
| John Valliant | CEO Founder | Profile | |
| Eric Hoffman | Senior Development | Profile | |
| Dmitri MD | Chief Officer | Profile | |
| Maria Stahl | Chief Officer | Profile | |
| Victor Paulus | VP Affairs | Profile |
Already Invested in Fusion PharmaceuticalsInc?
The danger of trading Fusion PharmaceuticalsInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Fusion PharmaceuticalsI is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Fusion PharmaceuticalsI. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Fusion PharmaceuticalsInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Fusion PharmaceuticalsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fusion PharmaceuticalsI's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fusion Pharmaceuticalsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fusion Pharmaceuticalsinc Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fusion PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Fusion Stock analysis
When running Fusion PharmaceuticalsI's price analysis, check to measure Fusion PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fusion PharmaceuticalsI is operating at the current time. Most of Fusion PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Fusion PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fusion PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Fusion PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Fusion PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion PharmaceuticalsI. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.45) | Revenue Per Share 0.032 | Quarterly Revenue Growth (1.00) | Return On Assets (0.25) | Return On Equity (0.49) |
The market value of Fusion PharmaceuticalsInc is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Fusion PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Fusion PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.